The TO_AITION project, completed this month (December 2025), has been investigating the biological causes of inflammation ...
MedPage Today on MSN
First At-Home Device Approved for Depression
The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...
The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...
A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and mini-brain models reveal a hidden neuroimmune story.
A breakthrough depression treatment offers relief in days, not weeks, according to our sponsors at BrainsAway. Major ...
WVNS Bluefield on MSN
New depression treatment could accelerate symptom relief
Millions of Americans living with major depressive disorder struggle to find treatment options that work for them. Providers ...
Laughing gas (nitrous oxide) appears to offer rapid mood improvement for people with severe or treatment-resistant depression ...
Morning Overview on MSN
Psilocybin may break depression loops by reshaping brain wiring
Psilocybin, the psychoactive compound in so-called magic mushrooms, is emerging as one of the most intriguing tools in modern ...
Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain through electrodes that are placed on the scalp.
Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results